N-/T-Type vs. L-Type Calcium Channel Blocker in Treating Chronic Kidney Disease: A Systematic Review and Meta-Analysis

• প্রধান লেখক: Mingming Zhao (লেখক), Ziyan Zhang (লেখক), Zhiyu Pan (লেখক), Sijia Ma (লেখক), Meiying Chang (লেখক), Jiao Fan (লেখক), Shunxuan Xue (লেখক), Yuejun Wang (লেখক), Hua Qu (লেখক), Yu Zhang (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: MDPI AG, 2023-02-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

Renin-angiotensin system (RAS) inhibitors and calcium channel blockers (CCB) are often used together in chronic kidney disease (CKD). The PubMed, EMBASE, and Cochrane Library databases were searched to identify randomized controlled trials (RCTs) in order to explore better subtypes of CCB for the tr...